RESEARCH TRIANGLE PARK, N.C., July 29, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE:ASXC), a global leader of innovative digital solutions for the operating room, announced today that a leading independent proxy advisory firm, Glass, Lewis & Co. ("Glass Lewis"), has recommended that Asensus Surgical stockholders vote "FOR" all proposals relating to the pending merger transaction with KARL STORZ Endoscopy-America, Inc. ("KARL STORZ"). The vote will take place at the Company's upcoming Special Meetin ...